{"id":1879,"date":"2024-03-27T14:21:28","date_gmt":"2024-03-27T14:21:28","guid":{"rendered":"https:\/\/stoxpo.com\/?p=1879"},"modified":"2024-03-27T14:21:30","modified_gmt":"2024-03-27T14:21:30","slug":"lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/","title":{"rendered":"LIXTE Biotechnology&#8217;s LB-100 Unveils Novel Cancer Treatment Strategy"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\">Pre-clinical Data Shows Potential to Force Cancer Cells into Less Malignant States<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">LIXTE Biotechnology Holdings, Inc. has made a groundbreaking advancement in cancer treatment with its lead clinical compound, LB-100, as revealed in a recent publication in Cancer Discovery. The pre-clinical data highlights LB-100&#8217;s ability to induce cancer cells to relinquish their cancer-causing properties, presenting a promising new avenue in cancer therapy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">LB-100 demonstrated a paradoxical effect by hyper-activating signals responsible for the uncontrolled proliferation of cancer cells, unlike conventional cancer treatments. When combined with a WEE1 kinase inhibitor, this approach proved highly effective in eliminating colon cancer cells in animal models and cell cultures, offering a potential solution to therapy resistance\u2014a major challenge in cancer treatment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Moreover, LB-100-induced resistance was associated with cancer cells adopting less malignant behaviors, inhibiting tumor formation in experimental models. This unique mechanism, coined &#8220;tumor suppressive drug resistance,&#8221; presents a novel concept in cancer therapy.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Led by Professor Ren\u00e9 Bernards, a renowned figure in molecular carcinogenesis, the research team&#8217;s findings open new horizons for cancer treatment. LIXTE&#8217;s CEO, Bas van der Baan, expressed optimism about clinically testing LB-100&#8217;s unique approach, marking a significant departure from conventional cancer therapies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Read original press release:<a href=\"https:\/\/finance.yahoo.com\/news\/scientific-publication-shows-lb-100-123000894.html\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">here<\/mark><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You might like this article:<a href=\"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/moderna-unveils-promising-new-vaccine-candidates-beyond-covid\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Moderna Unveils Promising New Vaccine Candidates Beyond COVID<\/mark><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pre-clinical Data Shows Potential to Force Cancer Cells into Less Malignant States LIXTE Biotechnology Holdings, Inc. has made a groundbreaking advancement in cancer treatment with its lead clinical compound, LB-100, as revealed in a recent publication in Cancer Discovery. The pre-clinical data highlights LB-100&#8217;s ability to induce cancer cells to relinquish their cancer-causing properties, presenting [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1422,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","video":"","gallery":"","source_name":"","source_url":"","via_name":"","via_url":"","override_template":"0","override":[{"template":"8","single_blog_custom":"","parallax":"1","fullscreen":"1","layout":"right-sidebar-narrow","sidebar":"author","second_sidebar":"single-right","sticky_sidebar":"1","share_position":"top","share_float_style":"share-monocrhome","show_share_counter":"0","show_view_counter":"0","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_author_image":"1","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"1","post_reading_time_wpm":"300","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","number_popup_post":"1","show_author_box":"1","show_post_related":"1","show_inline_post_related":"0"}],"override_image_size":"0","image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post":"0","trending_post_position":"meta","trending_post_label":"Trending","sponsored_post":"0","sponsored_post_label":"Sponsored by","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo_enable":"0","sponsored_post_logo":"","sponsored_post_desc":"","disable_ad":"0"},"jnews_primary_category":{"id":"","hide":""},"jnews_social_meta":{"fb_title":"","fb_description":"","fb_image":"","twitter_title":"","twitter_description":"","twitter_image":""},"jnews_override_counter":{"override_view_counter":"0","view_counter_number":"0","override_share_counter":"0","share_counter_number":"0","override_like_counter":"0","like_counter_number":"0","override_dislike_counter":"0","dislike_counter_number":"0"},"jnews_post_split":{"enable_post_split":"0","post_split":[{"template":"1","tag":"h2","numbering":"asc","mode":"normal","first":"0","enable_toc":"0","toc_type":"normal"}]},"footnotes":""},"categories":[308,358],"tags":[],"coauthors":[453],"class_list":["post-1879","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","category-micro-cap"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>LIXTE Biotechnology&#039;s LB-100 Unveils Novel Cancer Treatment Strategy - Stoxpo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LIXTE Biotechnology&#039;s LB-100 Unveils Novel Cancer Treatment Strategy - Stoxpo\" \/>\n<meta property=\"og:description\" content=\"Pre-clinical Data Shows Potential to Force Cancer Cells into Less Malignant States LIXTE Biotechnology Holdings, Inc. has made a groundbreaking advancement in cancer treatment with its lead clinical compound, LB-100, as revealed in a recent publication in Cancer Discovery. The pre-clinical data highlights LB-100&#8217;s ability to induce cancer cells to relinquish their cancer-causing properties, presenting [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/\" \/>\n<meta property=\"og:site_name\" content=\"Stoxpo\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-27T14:21:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-27T14:21:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Liliana Vida\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Liliana Vida\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\\\/\"},\"author\":{\"name\":\"Liliana Vida\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\"},\"headline\":\"LIXTE Biotechnology&#8217;s LB-100 Unveils Novel Cancer Treatment Strategy\",\"datePublished\":\"2024-03-27T14:21:28+00:00\",\"dateModified\":\"2024-03-27T14:21:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\\\/\"},\"wordCount\":226,\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"articleSection\":[\"Biotechnology\",\"Micro-Cap\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\\\/\",\"name\":\"LIXTE Biotechnology's LB-100 Unveils Novel Cancer Treatment Strategy - Stoxpo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"datePublished\":\"2024-03-27T14:21:28+00:00\",\"dateModified\":\"2024-03-27T14:21:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"radiology-2\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/27\\\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stoxpo.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LIXTE Biotechnology&#8217;s LB-100 Unveils Novel Cancer Treatment Strategy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"name\":\"Stoxpo\",\"description\":\"Stock Market &amp; Financial News\",\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stoxpo.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\",\"name\":\"Stoxpo\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"width\":250,\"height\":250,\"caption\":\"Stoxpo\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\",\"name\":\"Liliana Vida\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"caption\":\"Liliana Vida\"},\"description\":\"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/author\\\/stoxpo-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LIXTE Biotechnology's LB-100 Unveils Novel Cancer Treatment Strategy - Stoxpo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/","og_locale":"en_US","og_type":"article","og_title":"LIXTE Biotechnology's LB-100 Unveils Novel Cancer Treatment Strategy - Stoxpo","og_description":"Pre-clinical Data Shows Potential to Force Cancer Cells into Less Malignant States LIXTE Biotechnology Holdings, Inc. has made a groundbreaking advancement in cancer treatment with its lead clinical compound, LB-100, as revealed in a recent publication in Cancer Discovery. The pre-clinical data highlights LB-100&#8217;s ability to induce cancer cells to relinquish their cancer-causing properties, presenting [&hellip;]","og_url":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/","og_site_name":"Stoxpo","article_published_time":"2024-03-27T14:21:28+00:00","article_modified_time":"2024-03-27T14:21:30+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","type":"image\/jpeg"}],"author":"Liliana Vida","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Liliana Vida","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/#article","isPartOf":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/"},"author":{"name":"Liliana Vida","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1"},"headline":"LIXTE Biotechnology&#8217;s LB-100 Unveils Novel Cancer Treatment Strategy","datePublished":"2024-03-27T14:21:28+00:00","dateModified":"2024-03-27T14:21:30+00:00","mainEntityOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/"},"wordCount":226,"publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","articleSection":["Biotechnology","Micro-Cap"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/","url":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/","name":"LIXTE Biotechnology's LB-100 Unveils Novel Cancer Treatment Strategy - Stoxpo","isPartOf":{"@id":"https:\/\/stoxpo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/#primaryimage"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","datePublished":"2024-03-27T14:21:28+00:00","dateModified":"2024-03-27T14:21:30+00:00","breadcrumb":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/#primaryimage","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","width":2560,"height":1707,"caption":"radiology-2"},{"@type":"BreadcrumbList","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/27\/lixte-biotechnologys-lb-100-unveils-novel-cancer-treatment-strategy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stoxpo.com\/"},{"@type":"ListItem","position":2,"name":"LIXTE Biotechnology&#8217;s LB-100 Unveils Novel Cancer Treatment Strategy"}]},{"@type":"WebSite","@id":"https:\/\/stoxpo.com\/#website","url":"https:\/\/stoxpo.com\/","name":"Stoxpo","description":"Stock Market &amp; Financial News","publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stoxpo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stoxpo.com\/#organization","name":"Stoxpo","url":"https:\/\/stoxpo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","width":250,"height":250,"caption":"Stoxpo"},"image":{"@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1","name":"Liliana Vida","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6","url":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","caption":"Liliana Vida"},"description":"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.","url":"https:\/\/stoxpo.com\/index.php\/author\/stoxpo-com\/"}]}},"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/1879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=1879"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/1879\/revisions"}],"predecessor-version":[{"id":1880,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/1879\/revisions\/1880"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/1422"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=1879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=1879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=1879"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=1879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}